Analyst Scoreboard: 19 Ratings For AbbVie
Analyst Scoreboard: 19 Ratings For AbbVie
分析師評分板：艾伯維公司19條評級
Exploring Analyst Ratings: An In-Depth...19 analysts have expressed a variety of opinions on AbbVie (NYSE:ABBV) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的一個季度中，19位分析師對艾伯維公司（紐交所：ABBV）表達了各種意見，提供了從看好到看淡的多樣化觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，提供了對過去30天情緒變化的洞察，並與前幾個月進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $210.89, a high estimate of $231.00, and a low estimate of $191.00. This upward trend is evident, with the current average reflecting a 2.24% increase from the previous average price target of $206.27.
分析師通過對12個月價格目標的評估提供更深層次的見解，顯示平均目標爲210.89美元，高估計爲231.00美元，低估計爲191.00美元。這一上升趨勢顯而易見，目前的平均目標與之前的206.27美元平均價格目標相比，增長了2.24%。
Exploring Analyst Ratings: An In-Depth...
分析師評級:...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。